Industrial and infrastructure sectors are undergoing rapid modernisation
In the pharma sector, precision is non-negotiable and compliance is constant. Attention often focuses on formulations and manufacturing processes; yet the foundation of operational excellence lies in infrastructure — the systems that quietly ensure safety, efficiency and regulatory adherence. Jinali Gandhi, Director at Gandhi Automations, represents a new generation of leaders shaping this critical dimension of the industry
How critical is infrastructure automation in pharma facilities?
Infrastructure is integral to maintaining controlled environments. In pharma manufacturing, environmental stability is directly linked to product quality and regulatory adherence. Access systems must support air pressure control, thermal insulation, contamination prevention, and secure material flow.
Automation strengthens this framework. Rapid-action doors reduce air exchange in classified zones, insulated closures help maintain stringent temperature parameters, and sealed loading bays protect sensitive products during dispatch. By minimising manual dependency and ensuring operational consistency, automated systems enhance reliability across the facility.
In pharma, infrastructure is not peripheral — it is a compliance enabler.
What differentiates pharma infrastructure from other industrial sectors?
Pharma facilities operate with an exceptional level of precision. In this industry, even small environmental shifts can have serious implications, which means infrastructure has to be designed with far greater attention to detail. Everything must align with cleanroom classifications, inspection requirements and international regulatory standards from the outset.
For us at Gandhi Automations, it’s never just about supplying a door or dock solution. It’s about understanding how that system supports the wider environmental strategy of the facility. We look at durability, traceability, integrated safety and consistent performance under demanding conditions — because in pharma, infrastructure has to deliver certainty, not just functionality.
As a young leader in automation, what has shaped your professional journey?
Curiosity and consistency have shaped my journey the most. I made it a priority to understand the technical side of the business — how the products work, the regulations that govern them, and the markets we operate in. In engineering-driven sectors, credibility comes from delivering results, not titles. Over time, staying informed, decisive and accountable naturally builds trust with teams and clients alike.
How is automation transforming pharma logistics?
Automation is reshaping pharma logistics by making access systems smarter and more responsive. High-speed doors, insulated cold room doors and advanced loading bay equipment are now integrated with facility monitoring platforms, allowing better visibility and predictive maintenance. This reduces unexpected downtime and supports more efficient operational planning.
At the logistics end, well engineered dock systems and sealed loading systems improve vehicle turnaround while protecting temperature-sensitive products. The result is stronger supply chain continuity, improved energy efficiency and safer material handling — all critical in an industry where reliability directly impacts product integrity and regulatory compliance.
How do you see women contributing to the evolution of the industrial and infrastructure sectors?
Industrial and infrastructure sectors are undergoing rapid modernisation. Digital integration, sustainability objectives and global standardisation are redefining performance benchmarks. Diverse leadership plays an important role in navigating this transition.
Women leaders often bring analytical decision-making, collaborative execution and long-term strategic thinking — qualities that align strongly with infrastructure planning and risk management. As more women assume roles in engineering, manufacturing and international operations, the sector benefits from broader perspectives.